Axonics, Inc (AXNX) Enterprise Value to EBITDA Ratio
The growth of Axonics, Inc. (AXNX) is driven by the implementation of innovative neuromodulation systems, which makes the valuation chart on GURU.Markets with the 0.00 indicator particularly significant. The brand has earned recognition for miniature devices that restore quality of life for patients. However, success depends on the seamless import of electronics and the absence of geopolitical barriers during the international certification of high-tech software.
Comprehensive metric breakdowns and analytics for axonics.com (AXNX)
- current price and projected stock value:
- market capitalization details:
- business book valuation details:
- debt burden and liquidity indicators:
- financial results and valuation multiples details:
AXNX - Net Financial Result|Projected Future Earnings Axonics, Inc.|AXNX - Price to Earnings Ratio|Forward P/E Multiple Axonics, Inc.|AXNX - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Axonics, Inc|AXNX - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Axonics|AXNX - Earnings per share for the trailing year|Quarterly EPS earnings growth axonics.com|AXNX - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Axonics, Inc.
Analysis of all company metrics:Axonics Modulation Technologies AXNX
Portfolio managers highly value the operating model of Axonics, Inc. for its expansion within the neuromodulation segment. The EV/EBITDA multiple compares the total enterprise value with earnings before interest and taxes, allowing for an assessment of the real value of assets relative to the generated cash flow. An analysis of the EV/EBITDA trajectory for Axonics, Inc. confirms the effectiveness of Raymond Cohen's strategy, demonstrating market support for fundamental growth and the resilience of the issuer's position.
Competitor analysis
EV/EBITDA Multiple BSX (Boston Scientific Inc)|Total Company Value to Operating Income Before Depreciation Ratio Edwards Lifesciences Inc. (EW)|RMD: Enterprise Value to EBITDA Ratio|Company Value to Operating Income Before Depreciation Ratio PODD|ZBH: EV/EBITDA Multiple|Company Value to EBITDA The Cooper Companies, Inc. (COO)|ALGN (Align Technology Inc) - EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation GMED (NuVasive)|Enterprise Value to EBITDA Ratio TMDX (TransMedics)|ATEC (atecspine.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Artivion AORT|ENOV - Enterprise Value to EBITDA Ratio|Integra - EV/EBITDA Multiple|Company Value to EBITDA Establishment Labs Inc|BBNX: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation IRMD|EMBC (Embecta) - EV/EBITDA Multiple|Tandem Diabetes Care Inc (TNDM) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple AXGN|Enterprise Value to EBITDA Ratio SI-BONE Medical SIBN|EV/EBITDA Multiple OFIX (Orthofix Medical Inc.)|EV/EBITDA Multiple bioventus.com BVS|KIDS - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|TMCI: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|SRTA (Strata Critical Medical Corp) - Enterprise Value to EBITDA Ratio|Carlsmed Medical - Business Value to Operating Income Before Depreciation|RXST (RxSight, Inc.) - EV/EBITDA Multiple|Company Value to EBITDA ClearPoint CLPT|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Stereotaxis (STXS)|Neuronetics Inc. (STIM) - Enterprise Value to EBITDA Multiple|Sight Sciences, Inc - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple orchestrabiomed.com OBIO|Anika - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio inspiremd.com NSPR|zhjmedical.com (ZJYL) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio VANI (Vivani Medical)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Xtant Medical Holdings, Inc.|Enterprise Value to EBITDA Ratio NeuroOne Medical Technologies Corp. (NMTC)|EV/EBITDA Multiple MODD|MYO - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Envoy Medical COCH|VVOS: Enterprise Value to Operating Income Before Depreciation|NVNO: Enterprise Value to EBITDA Ratio|Sintx Technologies - Enterprise Value to Operating Income Before Depreciation Ratio|TNON: EV/EBITDA Multiple|rewalk.com (LFWD) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio AMIX|Enterprise Value to Operating Income Before Depreciation IVF (INVO Bioscience)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Bone Biologics Corporation (BBLG)|BIOL - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Dynatronics DYNT|FNA: Enterprise Value to Operating Income Before Depreciation|INVO Bio - EV/EBITDA Multiple
